Tahoe Therapeutics, which is building AI models of living cells, raised $30M led by Amplify Partners at a $120M valuation, taking its total funding to $42M — The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed …
Posted from: this blog via Microsoft Power Automate.